{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:12:21Z","timestamp":1790845941294,"version":"4.1.0"},"reference-count":216,"publisher":"Springer Science and Business Media LLC","issue":"1-3","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2320-B-037-023"],"award-info":[{"award-number":["NSTC 113-2320-B-037-023"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2321-B-255-001"],"award-info":[{"award-number":["NSTC 113-2321-B-255-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-Q113011"],"award-info":[{"award-number":["KMU-Q113011"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-024-09004-3","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T16:02:30Z","timestamp":1726675350000},"page":"21-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Neutrophils in Atopic Dermatitis"],"prefix":"10.1007","volume":"67","author":[{"given":"Chih-Chao","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Renz Marion Santiago","family":"Dela Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiyagarajan","family":"Raviraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Korinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsong-Long","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"9004_CR1","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3389\/fimmu.2019.02376","volume":"10","author":"CC Chiang","year":"2019","unstructured":"Chiang CC, Cheng WJ, Korinek M, Lin CY, Hwang TL (2019) Neutrophils in psoriasis. Front Immunol 10:2376. https:\/\/doi.org\/10.3389\/fimmu.2019.02376","journal-title":"Front Immunol"},{"key":"9004_CR2","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.immuni.2021.06.006","volume":"54","author":"GL Burn","year":"2021","unstructured":"Burn GL, Foti A, Marsman G, Patel DF, Zychlinsky A (2021) The neutrophil. Immunity 54:1377\u20131391. https:\/\/doi.org\/10.1016\/j.immuni.2021.06.006","journal-title":"Immunity"},{"key":"9004_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.871789","author":"M Mihlan","year":"2022","unstructured":"Mihlan M, Glaser KM, Epple MW, L\u00e4mmermann T (2022) Neutrophils: amoeboid migration and swarming dynamics in tissues. Frontiers in Cell and Developmental Biology. https:\/\/doi.org\/10.3389\/fcell.2022.871789","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"9004_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082867","author":"G Yang","year":"2020","unstructured":"Yang G et al (2020) Skin barrier abnormalities and immune dysfunction in atopic dermatitis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21082867","journal-title":"Int J Mol Sci"},{"key":"9004_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bj.2020.09.001","volume":"44","author":"SC Yang","year":"2021","unstructured":"Yang SC, Tsai YF, Pan YL, Hwang TL (2021) Understanding the role of neutrophils in acute respiratory distress syndrome. Biomed J 44:439\u2013446. https:\/\/doi.org\/10.1016\/j.bj.2020.09.001","journal-title":"Biomed J"},{"key":"9004_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera A, Soehnlein O, Kenne E (2022) Neutrophils in chronic inflammatory diseases. Cell Mol Immunol 19:177\u2013191. https:\/\/doi.org\/10.1038\/s41423-021-00832-3","journal-title":"Cell Mol Immunol"},{"key":"9004_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/ACI.0000000000000231","volume":"16","author":"K Hosoki","year":"2016","unstructured":"Hosoki K, Itazawa T, Boldogh I, Sur S (2016) Neutrophil recruitment by allergens contribute to allergic sensitization and allergic inflammation. Curr Opin Allergy Clin Immunol 16:45\u201350. https:\/\/doi.org\/10.1097\/ACI.0000000000000231","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"9004_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.neuron.2018.03.023","volume":"98","author":"X Dong","year":"2018","unstructured":"Dong X, Dong X (2018) Peripheral and central mechanisms of itch. Neuron 98:482\u2013494. https:\/\/doi.org\/10.1016\/j.neuron.2018.03.023","journal-title":"Neuron"},{"key":"9004_CR9","doi-asserted-by":"publisher","unstructured":"(2023) A study about how many people around the world have atopic dermatitis.\u00a0Br J Dermatol\u00a0190(1):e6. https:\/\/doi.org\/10.1093\/bjd\/ljad462","DOI":"10.1093\/bjd\/ljad462"},{"key":"9004_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/bjd\/ljad339","volume":"190","author":"J Tian","year":"2023","unstructured":"Tian J, Zhang D, Yang Y, Huang Y, Wang L, Yao X, Lu Q (2023) Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study. Br J Dermatol 190:55\u201361. https:\/\/doi.org\/10.1093\/bjd\/ljad339","journal-title":"Br J Dermatol"},{"key":"9004_CR11","doi-asserted-by":"publisher","first-page":"2450605","DOI":"10.1155\/2019\/2450605","volume":"2019","author":"D Bonamonte","year":"2019","unstructured":"Bonamonte D et al (2019) The role of the environmental risk factors in the pathogenesis and clinical outcome of atopic dermatitis. Biomed Res Int 2019:2450605. https:\/\/doi.org\/10.1155\/2019\/2450605","journal-title":"Biomed Res Int"},{"key":"9004_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.alit.2016.10.005","volume":"66","author":"H Murota","year":"2017","unstructured":"Murota H, Katayama I (2017) Exacerbating factors of itch in atopic dermatitis. Allergol Int 66:8\u201313. https:\/\/doi.org\/10.1016\/j.alit.2016.10.005","journal-title":"Allergol Int"},{"key":"9004_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4103\/ijd.IJD_427_17","volume":"63","author":"SB Batmaz","year":"2018","unstructured":"Batmaz SB (2018) Simple markers for systemic inflammation in pediatric atopic dermatitis patients. Indian J Dermatol 63:305\u2013310. https:\/\/doi.org\/10.4103\/ijd.IJD_427_17","journal-title":"Indian J Dermatol"},{"key":"9004_CR14","doi-asserted-by":"publisher","first-page":"adv00491","DOI":"10.2340\/00015555-3838","volume":"101","author":"S Inokuchi-Sakata","year":"2021","unstructured":"Inokuchi-Sakata S et al (2021) Role of eosinophil relative count and neutrophil-to-lymphocyte ratio in the assessment of severity of atopic dermatitis. Acta Derm Venereol 101:adv00491. https:\/\/doi.org\/10.2340\/00015555-3838","journal-title":"Acta Derm Venereol"},{"key":"9004_CR15","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.7417\/T.2017.2017","volume":"168","author":"M Dogru","year":"2017","unstructured":"Dogru M, Citli R (2017) The neutrophil-lymphocyte ratio in children with atopic dermatitis: a case-control study. Clin Ter 168:e262\u2013e265. https:\/\/doi.org\/10.7417\/T.2017.2017","journal-title":"Clin Ter"},{"key":"9004_CR16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jaci.2018.06.016","volume":"142","author":"TC Chan","year":"2018","unstructured":"Chan TC et al (2018) Atopic dermatitis in Chinese patients shows T(H)2\/T(H)17 skewing with psoriasiform features. J Allergy Clin Immunol 142:1013\u20131017. https:\/\/doi.org\/10.1016\/j.jaci.2018.06.016","journal-title":"J Allergy Clin Immunol"},{"key":"9004_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jaci.2013.04.046","volume":"132","author":"M Suarez-Farinas","year":"2013","unstructured":"Suarez-Farinas M et al (2013) Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol 132:361\u2013370. https:\/\/doi.org\/10.1016\/j.jaci.2013.04.046","journal-title":"J Allergy Clin Immunol"},{"key":"9004_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9030196","author":"L Bertino","year":"2020","unstructured":"Bertino L et al (2020). Oxidative stress and atopic dermatitis Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox9030196","journal-title":"Oxidative stress and atopic dermatitis. Antioxidants (Basel)"},{"key":"9004_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000323305","volume":"41","author":"R Agrawal","year":"2011","unstructured":"Agrawal R, Wisniewski JA, Woodfolk JA (2011) The role of regulatory T cells in atopic dermatitis. Curr Probl Dermatol 41:112\u2013124. https:\/\/doi.org\/10.1159\/000323305","journal-title":"Curr Probl Dermatol"},{"key":"9004_CR20","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1007\/s11033-021-07081-7","volume":"49","author":"J Salimian","year":"2022","unstructured":"Salimian J et al (2022) Atopic dermatitis: molecular, cellular, and clinical aspects. Mol Biol Rep 49:3333\u20133348. https:\/\/doi.org\/10.1007\/s11033-021-07081-7","journal-title":"Mol Biol Rep"},{"key":"9004_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21060753","author":"C Ng","year":"2016","unstructured":"Ng C et al (2016) Hyper IgE in childhood eczema and risk of asthma in Chinese children. Molecules. https:\/\/doi.org\/10.3390\/molecules21060753","journal-title":"Molecules"},{"key":"9004_CR22","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.sder.2012.07.006","volume":"31","author":"CN Ellis","year":"2012","unstructured":"Ellis CN, Mancini AJ, Paller AS, Simpson EL, Eichenfield LF (2012) Understanding and managing atopic dermatitis in adult patients. Semin Cutan Med Surg 31:S18-22. https:\/\/doi.org\/10.1016\/j.sder.2012.07.006","journal-title":"Semin Cutan Med Surg"},{"key":"9004_CR23","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","volume":"387","author":"S Weidinger","year":"2016","unstructured":"Weidinger S, Novak N (2016) Atopic dermatitis. Lancet 387:1109\u20131122. https:\/\/doi.org\/10.1016\/S0140-6736(15)00149-X","journal-title":"Lancet"},{"key":"9004_CR24","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jaci.2016.07.013","volume":"138","author":"H Esaki","year":"2016","unstructured":"Esaki H et al (2016) Early-onset pediatric atopic dermatitis is T(H)2 but also T(H)17 polarized in skin. J Allergy Clin Immunol 138:1639\u20131651. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.013","journal-title":"J Allergy Clin Immunol"},{"key":"9004_CR25","doi-asserted-by":"publisher","first-page":"7527859","DOI":"10.1155\/2020\/7527859","volume":"2020","author":"A Bozek","year":"2020","unstructured":"Bozek A, Zajac M, Krupka M (2020) Atopic dermatitis and psoriasis as overlapping syndromes. Mediators Inflamm 2020:7527859. https:\/\/doi.org\/10.1155\/2020\/7527859","journal-title":"Mediators Inflamm"},{"key":"9004_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2010.02.008","volume":"58","author":"Y Tokura","year":"2010","unstructured":"Tokura Y (2010) Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci 58:1\u20137. https:\/\/doi.org\/10.1016\/j.jdermsci.2010.02.008","journal-title":"J Dermatol Sci"},{"key":"9004_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2332\/allergolint.11-RA-0371","volume":"61","author":"N Fuiano","year":"2012","unstructured":"Fuiano N, Incorvaia C (2012) Dissecting the causes of atopic dermatitis in children: less foods, more mites. Allergol Int 61:231\u2013243. https:\/\/doi.org\/10.2332\/allergolint.11-RA-0371","journal-title":"Allergol Int"},{"key":"9004_CR28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jaci.2004.01.778","volume":"113","author":"S Illi","year":"2004","unstructured":"Illi S et al (2004) The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 113:925\u2013931. https:\/\/doi.org\/10.1016\/j.jaci.2004.01.778","journal-title":"J Allergy Clin Immunol"},{"key":"9004_CR29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12016-011-8252-4","volume":"41","author":"FT Liu","year":"2011","unstructured":"Liu FT, Goodarzi H, Chen HY (2011) IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol 41:298\u2013310. https:\/\/doi.org\/10.1007\/s12016-011-8252-4","journal-title":"Clin Rev Allergy Immunol"},{"key":"9004_CR30","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.jaci.2019.11.047","volume":"145","author":"LC Tsoi","year":"2020","unstructured":"Tsoi LC et al (2020) Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses. J Allergy Clin Immunol 145:1406\u20131415. https:\/\/doi.org\/10.1016\/j.jaci.2019.11.047","journal-title":"J Allergy Clin Immunol"},{"key":"9004_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41598-022-26637-6","volume":"13","author":"M Scibiorek","year":"2023","unstructured":"Scibiorek M et al (2023) IL-4R\u03b1 signalling in B cells and T cells play differential roles in acute and chronic atopic dermatitis. Sci Rep 13:144. https:\/\/doi.org\/10.1038\/s41598-022-26637-6","journal-title":"Sci Rep"},{"key":"9004_CR32","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","volume":"130","author":"JK Gittler","year":"2012","unstructured":"Gittler JK et al (2012) Progressive activation of TH2\/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. Journal of Allergy and Clinical Immunology 130:1344\u20131354. https:\/\/doi.org\/10.1016\/j.jaci.2012.07.012","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"9004_CR33","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1038\/jid.2008.283","volume":"128","author":"AD Cesare","year":"2008","unstructured":"Cesare AD, Meglio PD, Nestle FO (2008) A role for Th17 cells in the immunopathogenesis of atopic dermatitis? J Investig Dermatol 128:2569\u20132571. https:\/\/doi.org\/10.1038\/jid.2008.283","journal-title":"J Investig Dermatol"},{"key":"9004_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-024-08995-3","author":"Y Chen","year":"2024","unstructured":"Chen Y et al (2024) Atopic dermatitis and psoriasis: similarities and differences in metabolism and microbiome. Clin Rev Allergy Immunol. https:\/\/doi.org\/10.1007\/s12016-024-08995-3","journal-title":"Clin Rev Allergy Immunol"},{"key":"9004_CR35","doi-asserted-by":"publisher","first-page":"eaax2945","DOI":"10.1126\/scitranslmed.aax2945","volume":"11","author":"Y-L Chen","year":"2019","unstructured":"Chen Y-L et al (2019) Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis. Science Translational Medicine 11:eaax2945. https:\/\/doi.org\/10.1126\/scitranslmed.aax2945","journal-title":"Science Translational Medicine"},{"key":"9004_CR36","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jaci.2012.06.044","volume":"130","author":"DF Choy","year":"2012","unstructured":"Choy DF et al (2012) Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation. J Allergy Clin Immunol 130:1335-1343.e1335. https:\/\/doi.org\/10.1016\/j.jaci.2012.06.044","journal-title":"J Allergy Clin Immunol"},{"key":"9004_CR37","doi-asserted-by":"publisher","first-page":"109805","DOI":"10.1016\/j.clim.2023.109805","volume":"256","author":"C Zheng","year":"2023","unstructured":"Zheng C, Cao T, Ye C, Zou Y (2023) Neutrophil recruitment by CD4 tissue-resident memory T cells induces chronic recurrent inflammation in atopic dermatitis. Clin Immunol 256:109805. https:\/\/doi.org\/10.1016\/j.clim.2023.109805","journal-title":"Clin Immunol"},{"key":"9004_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2021.04.006","author":"CH Li","year":"2021","unstructured":"Li CH et al (2021) Immunological map in COVID-19. J Microbiol Immunol Infect. https:\/\/doi.org\/10.1016\/j.jmii.2021.04.006","journal-title":"J Microbiol Immunol Infect"},{"key":"9004_CR39","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ajem.2019.10.023","volume":"38","author":"Z Huang","year":"2020","unstructured":"Huang Z, Fu Z, Huang W, Huang K (2020) Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis. Am J Emerg Med 38:641\u2013647. https:\/\/doi.org\/10.1016\/j.ajem.2019.10.023","journal-title":"Am J Emerg Med"},{"key":"9004_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/17476348.2019.1675517","volume":"14","author":"AG El-Gazzar","year":"2020","unstructured":"El-Gazzar AG, Kamel MH, Elbahnasy OKM, El-Naggar ME (2020) Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients. Expert Rev Respir Med 14:111\u2013116. https:\/\/doi.org\/10.1080\/17476348.2019.1675517","journal-title":"Expert Rev Respir Med"},{"key":"9004_CR41","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.12659\/msm.900212","volume":"23","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Ma W (2017) Assessment of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in atopic dermatitis patients. Med Sci Monit 23:1340\u20131346. https:\/\/doi.org\/10.12659\/msm.900212","journal-title":"Med Sci Monit"},{"key":"9004_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s001050050573","volume":"48","author":"I B\u00f6hm","year":"1997","unstructured":"B\u00f6hm I, Bauer R (1997) Th1 cells, Th2 cells and atopic dermatitis. Hautarzt 48:223\u2013227. https:\/\/doi.org\/10.1007\/s001050050573","journal-title":"Hautarzt"},{"key":"9004_CR43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri3831","volume":"15","author":"TA Wynn","year":"2015","unstructured":"Wynn TA (2015) Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol 15:271\u2013282. https:\/\/doi.org\/10.1038\/nri3831","journal-title":"Nat Rev Immunol"},{"key":"9004_CR44","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.1038\/s41467-021-26460-z","volume":"12","author":"Z Zheng","year":"2021","unstructured":"Zheng Z et al (2021) Lung mesenchymal stromal cells influenced by Th2 cytokines mobilize neutrophils and facilitate metastasis by producing complement C3. Nat Commun 12:6202. https:\/\/doi.org\/10.1038\/s41467-021-26460-z","journal-title":"Nat Commun"},{"key":"9004_CR45","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1046\/j.1365-2133.2000.03535.x","volume":"142","author":"R Rukwied","year":"2000","unstructured":"Rukwied R, Lischetzki G, Mcglone F, Heyer G, Schmelz M (2000) Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. Br J Dermatol 142:1114\u20131120. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03535.x","journal-title":"Br J Dermatol"},{"key":"9004_CR46","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.immuni.2020.12.017","volume":"54","author":"J Dudeck","year":"2021","unstructured":"Dudeck J et al (2021) Directional mast cell degranulation of tumor necrosis factor into blood vessels primes neutrophil extravasation. Immunity 54:468-483.e465. https:\/\/doi.org\/10.1016\/j.immuni.2020.12.017","journal-title":"Immunity"},{"key":"9004_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature12655","volume":"503","author":"Y Nakamura","year":"2013","unstructured":"Nakamura Y et al (2013) Staphylococcus \u03b4-toxin induces allergic skin disease by activating mast cells. Nature 503:397\u2013401. https:\/\/doi.org\/10.1038\/nature12655","journal-title":"Nature"},{"key":"9004_CR48","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s00011-004-1307-8","volume":"53","author":"R Schramm","year":"2004","unstructured":"Schramm R, Thorlacius H (2004) Neutrophil recruitment in mast cell-dependent inflammation: inhibitory mechanisms of glucocorticoids. Inflamm Res 53:644\u2013652. https:\/\/doi.org\/10.1007\/s00011-004-1307-8","journal-title":"Inflamm Res"},{"key":"9004_CR49","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000520972","volume":"14","author":"G Pejler","year":"2022","unstructured":"Pejler G et al (2022) Mast cell tryptase potentiates neutrophil extracellular trap formation. J Innate Immun 14:433\u2013446. https:\/\/doi.org\/10.1159\/000520972","journal-title":"J Innate Immun"},{"key":"9004_CR50","first-page":"83","volume":"73","author":"K Neuber","year":"1991","unstructured":"Neuber K, Hilger RA, Konig W (1991) Interleukin-3, interleukin-8, FMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis. Immunology 73:83\u201387","journal-title":"Immunology"},{"key":"9004_CR51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/adc.70.2.119","volume":"70","author":"H Kimata","year":"1994","unstructured":"Kimata H, Lindley I (1994) Detection of plasma interleukin-8 in atopic dermatitis. Arch Dis Child 70:119\u2013122. https:\/\/doi.org\/10.1136\/adc.70.2.119","journal-title":"Arch Dis Child"},{"key":"9004_CR52","doi-asserted-by":"publisher","first-page":"E4061","DOI":"10.1073\/pnas.1525474113","volume":"113","author":"R Tokumasu","year":"2016","unstructured":"Tokumasu R et al (2016) Dose-dependent role of claudin-1 in vivo in orchestrating features of atopic dermatitis. Proc Natl Acad Sci 113:E4061\u2013E4068. https:\/\/doi.org\/10.1073\/pnas.1525474113","journal-title":"Proc Natl Acad Sci"},{"key":"9004_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/pai.12481","volume":"27","author":"C Cuppari","year":"2016","unstructured":"Cuppari C et al (2016) HMGB1 levels in children with atopic eczema\/dermatitis syndrome (AEDS). Pediatr Allergy Immunol 27:99\u2013102. https:\/\/doi.org\/10.1111\/pai.12481","journal-title":"Pediatr Allergy Immunol"},{"key":"9004_CR54","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1016\/j.celrep.2019.10.104","volume":"29","author":"E Hoste","year":"2019","unstructured":"Hoste E et al (2019) Epithelial HMGB1 delays skin wound healing and drives tumor initiation by priming neutrophils for NET formation. Cell Rep 29:2689-2701.e2684. https:\/\/doi.org\/10.1016\/j.celrep.2019.10.104","journal-title":"Cell Rep"},{"key":"9004_CR55","doi-asserted-by":"publisher","first-page":"6060","DOI":"10.1007\/s12035-024-03959-2","volume":"61","author":"S Mu","year":"2024","unstructured":"Mu S et al (2024) SIRT1-Mediated HMGB1 deacetylation suppresses neutrophil extracellular traps related to blood\u2013brain barrier impairment after cerebral venous thrombosis. Mol Neurobiol 61:6060\u20136076. https:\/\/doi.org\/10.1007\/s12035-024-03959-2","journal-title":"Mol Neurobiol"},{"key":"9004_CR56","doi-asserted-by":"publisher","first-page":"113148","DOI":"10.1016\/j.celrep.2023.113148","volume":"42","author":"J Focken","year":"2023","unstructured":"Focken J et al (2023) Neutrophil extracellular traps enhance S aureus skin colonization by oxidative stress induction and downregulation of epidermal barrier genes. Cell Rep 42:113148. https:\/\/doi.org\/10.1016\/j.celrep.2023.113148","journal-title":"Cell Rep"},{"key":"9004_CR57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022343118","author":"N Senda","year":"2021","unstructured":"Senda N et al (2021) HMGB1-mediated chromatin remodeling attenuates Il24 gene expression for the protection from allergic contact dermatitis. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2022343118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9004_CR58","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s10753-021-01608-7","volume":"45","author":"MP Correa","year":"2022","unstructured":"Correa MP et al (2022) Expression pattern and immunoregulatory roles of galectin-1 and galectin-3 in atopic dermatitis and psoriasis. Inflammation 45:1133\u20131145. https:\/\/doi.org\/10.1007\/s10753-021-01608-7","journal-title":"Inflammation"},{"key":"9004_CR59","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00109-017-1566-9","volume":"95","author":"MP Corr\u00eaa","year":"2017","unstructured":"Corr\u00eaa MP, Andrade FEC, Gimenes AD, Gil CD (2017) Anti-inflammatory effect of galectin-1 in a murine model of atopic dermatitis. J Mol Med 95:1005\u20131015. https:\/\/doi.org\/10.1007\/s00109-017-1566-9","journal-title":"J Mol Med"},{"key":"9004_CR60","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cell.2020.12.035","volume":"184","author":"SS Mali","year":"2021","unstructured":"Mali SS, Bautista DM (2021) Basophils add fuel to the flame of eczema itch. Cell 184:294\u2013296. https:\/\/doi.org\/10.1016\/j.cell.2020.12.035","journal-title":"Cell"},{"key":"9004_CR61","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.48448","author":"CM Walsh","year":"2019","unstructured":"Walsh CM et al (2019) Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis. Elife. https:\/\/doi.org\/10.7554\/eLife.48448","journal-title":"Elife"},{"key":"9004_CR62","doi-asserted-by":"publisher","first-page":"7393","DOI":"10.3390\/ijms22147393","volume":"22","author":"T Hou","year":"2021","unstructured":"Hou T et al (2021) IL-37 targets TSLP-primed basophils to alleviate atopic dermatitis. Int J Mol Sci 22:7393. https:\/\/doi.org\/10.3390\/ijms22147393","journal-title":"Int J Mol Sci"},{"key":"9004_CR63","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.immuni.2012.06.018","volume":"37","author":"MK Oyoshi","year":"2012","unstructured":"Oyoshi MK et al (2012) Leukotriene B4-driven neutrophil recruitment to the skin is essential for allergic skin inflammation. Immunity 37:747\u2013758. https:\/\/doi.org\/10.1016\/j.immuni.2012.06.018","journal-title":"Immunity"},{"key":"9004_CR64","doi-asserted-by":"publisher","first-page":"12189","DOI":"10.7150\/thno.48028","volume":"10","author":"C Yin","year":"2020","unstructured":"Yin C et al (2020) IL-33\/ST2 induces neutrophil-dependent reactive oxygen species production and mediates gout pain. Theranostics 10:12189\u201312203. https:\/\/doi.org\/10.7150\/thno.48028","journal-title":"Theranostics"},{"key":"9004_CR65","doi-asserted-by":"publisher","unstructured":"Moosbrugger-Martinz V et al (2022) Revisiting the roles of filaggrin in atopic dermatitis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23105318","DOI":"10.3390\/ijms23105318"},{"key":"9004_CR66","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.clim.2014.12.001","volume":"156","author":"S Hoff","year":"2015","unstructured":"Hoff S, Oyoshi MK, Macpherson A, Geha RS (2015) The microbiota is important for IL-17A expression and neutrophil infiltration in lesional skin of Flg(ft\/ft) mice. Clin Immunol 156:128\u2013130. https:\/\/doi.org\/10.1016\/j.clim.2014.12.001","journal-title":"Clin Immunol"},{"key":"9004_CR67","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/intimm\/dxq027","volume":"22","author":"PF Cheung","year":"2010","unstructured":"Cheung PF et al (2010) Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis. Int Immunol 22:453\u2013467. https:\/\/doi.org\/10.1093\/intimm\/dxq027","journal-title":"Int Immunol"},{"key":"9004_CR68","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jid.2016.09.037","volume":"137","author":"B Ungar","year":"2017","unstructured":"Ungar B et al (2017) An integrated model of atopic dermatitis biomarkers highlights the systemic nature of the disease. J Invest Dermatol 137:603\u2013613. https:\/\/doi.org\/10.1016\/j.jid.2016.09.037","journal-title":"J Invest Dermatol"},{"key":"9004_CR69","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ymeth.2011.12.003","volume":"56","author":"H Kalish","year":"2012","unstructured":"Kalish H, Phillips TM (2012) Assessment of chemokine profiles in human skin biopsies by an immunoaffinity capillary electrophoresis chip. Methods 56:198\u2013203. https:\/\/doi.org\/10.1016\/j.ymeth.2011.12.003","journal-title":"Methods"},{"key":"9004_CR70","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1007\/s10753-019-01086-y","volume":"42","author":"H Sakai","year":"2019","unstructured":"Sakai H et al (2019) Interference of skin scratching attenuates accumulation of neutrophils in murine allergic contact dermatitis model. Inflammation 42:2226\u20132235. https:\/\/doi.org\/10.1007\/s10753-019-01086-y","journal-title":"Inflammation"},{"key":"9004_CR71","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1097\/j.pain.0000000000000208","volume":"156","author":"L Qu","year":"2015","unstructured":"Qu L, Fu K, Yang J, Shimada SG, LaMotte RH (2015) CXCR3 chemokine receptor signaling mediates itch in experimental allergic contact dermatitis. Pain 156:1737\u20131746. https:\/\/doi.org\/10.1097\/j.pain.0000000000000208","journal-title":"Pain"},{"key":"9004_CR72","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000357780","volume":"21","author":"R Vazirinejad","year":"2014","unstructured":"Vazirinejad R, Ahmadi Z, Kazemi Arababadi M, Hassanshahi G, Kennedy D (2014) The biological functions, structure and sources of CXCL10 and its outstanding part in the pathophysiology of multiple sclerosis. NeuroImmunoModulation 21:322\u2013330. https:\/\/doi.org\/10.1159\/000357780","journal-title":"NeuroImmunoModulation"},{"key":"9004_CR73","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000339666","volume":"160","author":"T Amarbayasgalan","year":"2013","unstructured":"Amarbayasgalan T, Takahashi H, Dekio I, Morita E (2013) Interleukin-8 content in the stratum corneum as an indicator of the severity of inflammation in the lesions of atopic dermatitis. Int Arch Allergy Immunol 160:63\u201374. https:\/\/doi.org\/10.1159\/000339666","journal-title":"Int Arch Allergy Immunol"},{"key":"9004_CR74","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/cvr\/cvy130","volume":"114","author":"MA Mawhin","year":"2018","unstructured":"Mawhin MA et al (2018) Neutrophils recruited by leukotriene B4 induce features of plaque destabilization during endotoxaemia. Cardiovasc Res 114:1656\u20131666. https:\/\/doi.org\/10.1093\/cvr\/cvy130","journal-title":"Cardiovasc Res"},{"key":"9004_CR75","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature12175","volume":"498","author":"T Lammermann","year":"2013","unstructured":"Lammermann T et al (2013) Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature 498:371\u2013375. https:\/\/doi.org\/10.1038\/nature12175","journal-title":"Nature"},{"key":"9004_CR76","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/intimm\/dxy087","volume":"31","author":"T Honda","year":"2019","unstructured":"Honda T, Kabashima K (2019) Prostanoids and leukotrienes in the pathophysiology of atopic dermatitis and psoriasis. Int Immunol 31:589\u2013595. https:\/\/doi.org\/10.1093\/intimm\/dxy087","journal-title":"Int Immunol"},{"key":"9004_CR77","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg8047","author":"SE Henrickson","year":"2021","unstructured":"Henrickson SE (2021) Basophils getting on your nerves? Itching for clarity on flares in atopic dermatitis. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.abg8047","journal-title":"Sci Immunol"},{"key":"9004_CR78","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/aps.2013.88","volume":"34","author":"SH He","year":"2013","unstructured":"He SH, Zhang HY, Zeng XN, Chen D, Yang PC (2013) Mast cells and basophils are essential for allergies: mechanisms of allergic inflammation and a proposed procedure for diagnosis. Acta Pharmacol Sin 34:1270\u20131283. https:\/\/doi.org\/10.1038\/aps.2013.88","journal-title":"Acta Pharmacol Sin"},{"key":"9004_CR79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022087118","author":"T Voisin","year":"2021","unstructured":"Voisin T et al (2021) The CysLT(2)R receptor mediates leukotriene C(4)-driven acute and chronic itch. Proc Natl Acad Sci U SA. https:\/\/doi.org\/10.1073\/pnas.2022087118","journal-title":"Proc Natl Acad Sci U SA"},{"key":"9004_CR80","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0091-6749(89)90132-2","volume":"83","author":"K Fogh","year":"1989","unstructured":"Fogh K, Herlin T, Kragballe K (1989) Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations. J Allergy Clin Immunol 83:450\u2013455. https:\/\/doi.org\/10.1016\/0091-6749(89)90132-2","journal-title":"J Allergy Clin Immunol"},{"key":"9004_CR81","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.1021\/pr5007069","volume":"13","author":"Y Huang","year":"2014","unstructured":"Huang Y et al (2014) Serum metabolomics study and eicosanoid analysis of childhood atopic dermatitis based on liquid chromatography-mass spectrometry. J Proteome Res 13:5715\u20135723. https:\/\/doi.org\/10.1021\/pr5007069","journal-title":"J Proteome Res"},{"key":"9004_CR82","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1164\/rccm.201909-1869OC","volume":"203","author":"J Kolmert","year":"2021","unstructured":"Kolmert J et al (2021) Urinary leukotriene E4 and prostaglandin D2 metabolites increase in adult and childhood severe asthma characterized by type 2 inflammation. A Clinical Observational Study. Am J Respir Crit Care Med 203:37\u201353. https:\/\/doi.org\/10.1164\/rccm.201909-1869OC","journal-title":"Am J Respir Crit Care Med"},{"key":"9004_CR83","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.anai.2019.10.013","volume":"124","author":"H He","year":"2020","unstructured":"He H et al (2020) Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic dermatitis. Ann Allergy Asthma Immunol 124:70\u201378. https:\/\/doi.org\/10.1016\/j.anai.2019.10.013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"9004_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10050697","author":"O Simonetti","year":"2021","unstructured":"Simonetti O et al (2021) Oxidative stress and alterations of paraoxonases in atopic dermatitis. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox10050697","journal-title":"Antioxidants (Basel)"},{"key":"9004_CR85","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jmii.2020.01.009","volume":"54","author":"CY Wei Choo","year":"2021","unstructured":"Wei Choo CY et al (2021) Oxidative stress is associated with atopic indices in relation to childhood rhinitis and asthma. J Microbiol Immunol Infect 54:466\u2013473. https:\/\/doi.org\/10.1016\/j.jmii.2020.01.009","journal-title":"J Microbiol Immunol Infect"},{"key":"9004_CR86","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/1523-1747.ep12616644","volume":"99","author":"O Wiedow","year":"1992","unstructured":"Wiedow O, Wiese F, Streit V, Kalm C, Christophers E (1992) Lesional elastase activity in psoriasis, contact dermatitis, and atopic dermatitis. J Invest Dermatol 99:306\u2013309. https:\/\/doi.org\/10.1111\/1523-1747.ep12616644","journal-title":"J Invest Dermatol"},{"key":"9004_CR87","doi-asserted-by":"publisher","first-page":"13875","DOI":"10.1074\/jbc.M115.642736","volume":"290","author":"P Zhao","year":"2015","unstructured":"Zhao P et al (2015) Neutrophil elastase activates protease-activated receptor-2 (PAR2) and transient receptor potential vanilloid 4 (TRPV4) to cause inflammation and pain. J Biol Chem 290:13875\u201313887. https:\/\/doi.org\/10.1074\/jbc.M115.642736","journal-title":"J Biol Chem"},{"key":"9004_CR88","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.3389\/fimmu.2020.01740","volume":"11","author":"T Buhl","year":"2020","unstructured":"Buhl T et al (2020) Protease-activated receptor-2 regulates neuro-epidermal communication in atopic dermatitis. Front Immunol 11:1740. https:\/\/doi.org\/10.3389\/fimmu.2020.01740","journal-title":"Front Immunol"},{"key":"9004_CR89","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12959-019-0194-8","volume":"17","author":"DM Heuberger","year":"2019","unstructured":"Heuberger DM, Schuepbach RA (2019) Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases. Thromb J 17:4. https:\/\/doi.org\/10.1186\/s12959-019-0194-8","journal-title":"Thromb J"},{"key":"9004_CR90","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jid.2018.08.019","volume":"139","author":"TP Barr","year":"2019","unstructured":"Barr TP et al (2019) PAR2 pepducin-based suppression of inflammation and itch in atopic dermatitis models. J Invest Dermatol 139:412\u2013421. https:\/\/doi.org\/10.1016\/j.jid.2018.08.019","journal-title":"J Invest Dermatol"},{"key":"9004_CR91","doi-asserted-by":"publisher","first-page":"53","DOI":"10.18821\/1560-9588-2016-19-1-53-58","volume":"19","author":"IV Elistratova","year":"2016","unstructured":"Elistratova IV, Morozov SG, Zakharova IA (2016) Expression proteaseinhibitors receptor PAR-2 on neutrophils peripheral blood of patients with atopic dermatitis and their relation with heat shock proteins HSP90. RJSKD 19:53\u201358. https:\/\/doi.org\/10.18821\/1560-9588-2016-19-1-53-58","journal-title":"RJSKD"},{"key":"9004_CR92","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20082242","volume":"206","author":"A Briot","year":"2009","unstructured":"Briot A et al (2009) Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 206:1135\u20131147. https:\/\/doi.org\/10.1084\/jem.20082242","journal-title":"J Exp Med"},{"key":"9004_CR93","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jaci.2014.05.048","volume":"134","author":"PM Elias","year":"2014","unstructured":"Elias PM, Wakefield JS (2014) Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 134:781\u2013791. https:\/\/doi.org\/10.1016\/j.jaci.2014.05.048. (e781)","journal-title":"J Allergy Clin Immunol"},{"key":"9004_CR94","doi-asserted-by":"publisher","first-page":"2721469","DOI":"10.1155\/2016\/2721469","volume":"2016","author":"H Ji","year":"2016","unstructured":"Ji H, Li XK (2016) Oxidative stress in atopic dermatitis. Oxid Med Cell Longev 2016:2721469. https:\/\/doi.org\/10.1155\/2016\/2721469","journal-title":"Oxid Med Cell Longev"},{"key":"9004_CR95","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/imr.12447","volume":"273","author":"J El-Benna","year":"2016","unstructured":"El-Benna J et al (2016) Priming of the neutrophil respiratory burst: role in host defense and inflammation. Immunol Rev 273:180\u2013193. https:\/\/doi.org\/10.1111\/imr.12447","journal-title":"Immunol Rev"},{"key":"9004_CR96","doi-asserted-by":"publisher","first-page":"107233","DOI":"10.1016\/j.intimp.2020.107233","volume":"90","author":"LHA Cavalcante-Silva","year":"2021","unstructured":"Cavalcante-Silva LHA et al (2021) Neutrophils and COVID-19: the road so far. Int Immunopharmacol 90:107233. https:\/\/doi.org\/10.1016\/j.intimp.2020.107233","journal-title":"Int Immunopharmacol"},{"key":"9004_CR97","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/09537104.2020.1817360","volume":"32","author":"K Martinod","year":"2021","unstructured":"Martinod K, Deppermann C (2021) Immunothrombosis and thromboinflammation in host defense and disease. Platelets 32:314\u2013324. https:\/\/doi.org\/10.1080\/09537104.2020.1817360","journal-title":"Platelets"},{"key":"9004_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9010053","author":"A Trivedi","year":"2021","unstructured":"Trivedi A, Khan MA, Bade G, Talwar A (2021) Orchestration of neutrophil extracellular traps (Nets), a unique innate immune function during chronic obstructive pulmonary disease (COPD) development. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9010053","journal-title":"Biomedicines"},{"key":"9004_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010231","author":"A Bonaventura","year":"2020","unstructured":"Bonaventura A, Vecchie A, Abbate A, Montecucco F (2020) Neutrophil extracellular traps and cardiovascular diseases: an update. Cells. https:\/\/doi.org\/10.3390\/cells9010231","journal-title":"Cells"},{"key":"9004_CR100","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1158\/1078-0432.CCR-20-1319","volume":"27","author":"A Teijeira","year":"2021","unstructured":"Teijeira A et al (2021) IL8, Neutrophils, and NETs in a collusion against cancer immunity and immunotherapy. Clin Cancer Res 27:2383\u20132393. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-1319","journal-title":"Clin Cancer Res"},{"key":"9004_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091325","author":"LJ O'Neil","year":"2019","unstructured":"O\u2019Neil LJ, Kaplan MJ, Carmona-Rivera C (2019) The role of neutrophils and neutrophil extracellular traps in vascular damage in systemic lupus erythematosus. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8091325","journal-title":"J Clin Med"},{"key":"9004_CR102","doi-asserted-by":"publisher","first-page":"578129","DOI":"10.3389\/fimmu.2020.578129","volume":"11","author":"W Song","year":"2020","unstructured":"Song W, Ye J, Pan N, Tan C, Herrmann M (2020) Neutrophil extracellular traps tied to rheumatoid arthritis: points to ponder. Front Immunol 11:578129. https:\/\/doi.org\/10.3389\/fimmu.2020.578129","journal-title":"Front Immunol"},{"key":"9004_CR103","doi-asserted-by":"publisher","first-page":"31119","DOI":"10.1038\/srep31119","volume":"6","author":"SC Hu","year":"2016","unstructured":"Hu SC et al (2016) Neutrophil extracellular trap formation is increased in psoriasis and induces human beta-defensin-2 production in epidermal keratinocytes. Sci Rep 6:31119. https:\/\/doi.org\/10.1038\/srep31119","journal-title":"Sci Rep"},{"key":"9004_CR104","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s10517-011-1224-0","volume":"150","author":"SG Sapuntsova","year":"2011","unstructured":"Sapuntsova SG et al (2011) Status of free-radical oxidation and proliferation processes in patients with atopic dermatitis and lichen planus. Bull Exp Biol Med 150:690\u2013692. https:\/\/doi.org\/10.1007\/s10517-011-1224-0","journal-title":"Bull Exp Biol Med"},{"key":"9004_CR105","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/bjd.18643","volume":"182","author":"H Alexander","year":"2020","unstructured":"Alexander H et al (2020) The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group. Br J Dermatol 182:1331\u20131342. https:\/\/doi.org\/10.1111\/bjd.18643","journal-title":"Br J Dermatol"},{"key":"9004_CR106","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10989-024-10609-7","volume":"30","author":"C-Y Hsu","year":"2024","unstructured":"Hsu C-Y et al (2024) Antimicrobial peptides (AMPs): new perspectives on their function in dermatological diseases. Int J Pept Res Ther 30:33. https:\/\/doi.org\/10.1007\/s10989-024-10609-7","journal-title":"Int J Pept Res Ther"},{"key":"9004_CR107","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/ijms21041314","volume":"21","author":"M Sugaya","year":"2020","unstructured":"Sugaya M (2020) The role of Th17-related cytokines in atopic dermatitis. Int J Mol Sci 21:1314. https:\/\/doi.org\/10.3390\/ijms21041314","journal-title":"Int J Mol Sci"},{"key":"9004_CR108","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jaci.2013.04.043","volume":"132","author":"N Dhingra","year":"2013","unstructured":"Dhingra N et al (2013) Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects T<sub>H<\/sub>17 pathway differences between these diseases. Journal of Allergy and Clinical Immunology 132:498-501.e493. https:\/\/doi.org\/10.1016\/j.jaci.2013.04.043","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"9004_CR109","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.alit.2019.02.006","volume":"68","author":"K Iwamoto","year":"2019","unstructured":"Iwamoto K, Moriwaki M, Miyake R, Hide M (2019) Staphylococcus aureus in atopic dermatitis: Strain-specific cell wall proteins and skin immunity. Allergol Int 68:309\u2013315. https:\/\/doi.org\/10.1016\/j.alit.2019.02.006","journal-title":"Allergol Int"},{"key":"9004_CR110","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.aller.2009.06.003","volume":"37","author":"WC Forte","year":"2009","unstructured":"Forte WC, Guardian VC, Mantovani PA, Dionigi PC, Menezes MC (2009) Evaluation of phagocytes in atopic dermatitis. Allergol Immunopathol (Madr) 37:302\u2013308. https:\/\/doi.org\/10.1016\/j.aller.2009.06.003","journal-title":"Allergol Immunopathol (Madr)"},{"key":"9004_CR111","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11882-017-0750-x","volume":"17","author":"T Gonzalez","year":"2017","unstructured":"Gonzalez T, Biagini Myers JM, Herr AB, Khurana Hershey GK (2017) Staphylococcal biofilms in atopic dermatitis. Curr Allergy Asthma Rep 17:81. https:\/\/doi.org\/10.1007\/s11882-017-0750-x","journal-title":"Curr Allergy Asthma Rep"},{"key":"9004_CR112","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/exd.14381","volume":"30","author":"K Bier","year":"2021","unstructured":"Bier K, Schittek B (2021) Beneficial effects of coagulase-negative Staphylococci on Staphylococcus aureus skin colonization. Exp Dermatol 30:1442\u20131452. https:\/\/doi.org\/10.1111\/exd.14381","journal-title":"Exp Dermatol"},{"key":"9004_CR113","doi-asserted-by":"publisher","first-page":"156634","DOI":"10.1016\/j.cyto.2024.156634","volume":"180","author":"DP De Donato","year":"2024","unstructured":"De Donato DP et al (2024) Staphylococcus aureus Serine protease-like protein A (SplA) induces IL-8 by keratinocytes and synergizes with IL-17A. Cytokine 180:156634. https:\/\/doi.org\/10.1016\/j.cyto.2024.156634","journal-title":"Cytokine"},{"key":"9004_CR114","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftw060","author":"WN Beavers","year":"2016","unstructured":"Beavers WN, Skaar EP (2016) Neutrophil-generated oxidative stress and protein damage in Staphylococcus aureus. Pathog Dis. https:\/\/doi.org\/10.1093\/femspd\/ftw060","journal-title":"Pathog Dis"},{"key":"9004_CR115","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jid.2019.10.017","volume":"140","author":"K Bitschar","year":"2020","unstructured":"Bitschar K et al (2020) Staphylococcus aureus skin colonization is enhanced by the interaction of neutrophil extracellular traps with keratinocytes. J Invest Dermatol 140:1054\u20131065. https:\/\/doi.org\/10.1016\/j.jid.2019.10.017. (e1054)","journal-title":"J Invest Dermatol"},{"key":"9004_CR116","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/molecules21040471","volume":"21","author":"C-K Wong","year":"2016","unstructured":"Wong C-K, Chu IM-T, Hon K-L, Tsang MS-M, Lam CW-K (2016) Aberrant expression of bacterial pattern recognition receptor NOD2 of basophils and microbicidal peptides in atopic dermatitis. Molecules 21:471. https:\/\/doi.org\/10.3390\/molecules21040471","journal-title":"Molecules"},{"key":"9004_CR117","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1080\/08923973.2020.1806869","volume":"42","author":"X Guo","year":"2020","unstructured":"Guo X et al (2020) HP-NAP ameliorates OXA-induced atopic dermatitis symptoms in mice. Immunopharmacol Immunotoxicol 42:416\u2013422. https:\/\/doi.org\/10.1080\/08923973.2020.1806869","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"9004_CR118","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1586\/1744666x.2014.967684","volume":"10","author":"A Cianferoni","year":"2014","unstructured":"Cianferoni A, Spergel J (2014) The importance of TSLP in allergic disease and its role as a potential therapeutic target. Expert Rev Clin Immunol 10:1463\u20131474. https:\/\/doi.org\/10.1586\/1744666x.2014.967684","journal-title":"Expert Rev Clin Immunol"},{"key":"9004_CR119","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/cei.13575","volume":"204","author":"P Chieosilapatham","year":"2021","unstructured":"Chieosilapatham P et al (2021) Keratinocytes: innate immune cells in atopic dermatitis. Clin Exp Immunol 204:296\u2013309. https:\/\/doi.org\/10.1111\/cei.13575","journal-title":"Clin Exp Immunol"},{"key":"9004_CR120","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaf8471","author":"EE West","year":"2016","unstructured":"West EE et al (2016) A TSLP-complement axis mediates neutrophil killing of methicillin-resistant Staphylococcus aureus. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aaf8471","journal-title":"Sci Immunol"},{"key":"9004_CR121","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","volume":"71","author":"LF Eichenfield","year":"2014","unstructured":"Eichenfield LF et al (2014) Guidelines of care for the management of atopic dermatitis: Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 71:116\u2013132. https:\/\/doi.org\/10.1016\/j.jaad.2014.03.023","journal-title":"J Am Acad Dermatol"},{"key":"9004_CR122","first-page":"133","volume":"107","author":"J Stouffer","year":"2023","unstructured":"Stouffer J, Chang JG (2023) Strategies for topical corticosteroid use in children and adults with eczema. Am Fam Physician 107:133\u2013134","journal-title":"Am Fam Physician"},{"key":"9004_CR123","doi-asserted-by":"publisher","first-page":"CD013356","DOI":"10.1002\/14651858.CD013356.pub2","volume":"3","author":"SJ Lax","year":"2022","unstructured":"Lax SJ et al (2022) Strategies for using topical corticosteroids in children and adults with eczema. The Cochrane Database of Systematic Reviews 3:CD013356. https:\/\/doi.org\/10.1002\/14651858.CD013356.pub2","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"9004_CR124","doi-asserted-by":"publisher","first-page":"e027239","DOI":"10.1136\/bmjopen-2018-027239","volume":"9","author":"KF van Halewijn","year":"2019","unstructured":"van Halewijn KF et al (2019) Different potencies of topical corticosteroids for a better treatment strategy in children with atopic dermatitis (the Rotterdam Eczema study): protocol for an observational cohort study with an embedded randomised open-label controlled trial. BMJ Open 9:e027239. https:\/\/doi.org\/10.1136\/bmjopen-2018-027239","journal-title":"BMJ Open"},{"key":"9004_CR125","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/jid.1952.72","volume":"19","author":"MB Sulzberger","year":"1952","unstructured":"Sulzberger MB, Witten VH (1952) The effect of topically applied compound F in selected dermatoses. J Invest Dermatol 19:101\u2013102. https:\/\/doi.org\/10.1038\/jid.1952.72","journal-title":"J Invest Dermatol"},{"key":"9004_CR126","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/B978-0-323-61211-1.00045-0","volume-title":"Comprehensive Dermatologic Drug Therapy","author":"C Camisa","year":"2020","unstructured":"Camisa C, Garofola C (2020) Topical corticosteroids. Comprehensive Dermatologic Drug Therapy, 4th edn. pp 511-527.e516. https:\/\/doi.org\/10.1016\/B978-0-323-61211-1.00045-0","edition":"4"},{"key":"9004_CR127","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1067\/mai.2000.105807","volume":"105","author":"PJ Hauk","year":"2000","unstructured":"Hauk PJ, Hamid QA, Chrousos GP, Leung DY (2000) Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol 105:782\u2013787. https:\/\/doi.org\/10.1067\/mai.2000.105807","journal-title":"J Allergy Clin Immunol"},{"key":"9004_CR128","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","volume":"42","author":"S Ramamoorthy","year":"2016","unstructured":"Ramamoorthy S, Cidlowski JA (2016) Corticosteroids: Mechanisms of action in health and disease. Rheum Dis Clin North Am 42:15\u201331. https:\/\/doi.org\/10.1016\/j.rdc.2015.08.002. (vii)","journal-title":"Rheum Dis Clin North Am"},{"key":"9004_CR129","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/bjd.15928","volume":"178","author":"AM Drucker","year":"2018","unstructured":"Drucker AM et al (2018) Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. Br J Dermatol 178:768\u2013775. https:\/\/doi.org\/10.1111\/bjd.15928","journal-title":"Br J Dermatol"},{"key":"9004_CR130","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s40265-020-01335-7","volume":"80","author":"M Newsom","year":"2020","unstructured":"Newsom M, Bashyam AM, Balogh EA, Feldman SR, Strowd LC (2020) New and emerging systemic treatments for atopic dermatitis. Drugs 80:1041\u20131052. https:\/\/doi.org\/10.1007\/s40265-020-01335-7","journal-title":"Drugs"},{"key":"9004_CR131","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1001\/jamadermatol.2022.0455","volume":"158","author":"AM Drucker","year":"2022","unstructured":"Drucker AM et al (2022) Systemic immunomodulatory treatments for atopic dermatitis: update of a living systematic review and network meta-analysis. JAMA Dermatol 158:523\u2013532. https:\/\/doi.org\/10.1001\/jamadermatol.2022.0455","journal-title":"JAMA Dermatol"},{"key":"9004_CR132","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40257-018-0413-2","volume":"20","author":"H He","year":"2019","unstructured":"He H, Guttman-Yassky E (2019) JAK inhibitors for atopic dermatitis: an update. Am J Clin Dermatol 20:181\u2013192. https:\/\/doi.org\/10.1007\/s40257-018-0413-2","journal-title":"Am J Clin Dermatol"},{"key":"9004_CR133","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41423-023-00992-4","volume":"20","author":"P Facheris","year":"2023","unstructured":"Facheris P, Jeffery J, Del Duca E, Guttman-Yassky E (2023) The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment. Cell Mol Immunol 20:448\u2013474. https:\/\/doi.org\/10.1038\/s41423-023-00992-4","journal-title":"Cell Mol Immunol"},{"key":"9004_CR134","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1097\/itx.0000000000000053","volume":"6","author":"K Sakai","year":"2021","unstructured":"Sakai K, Sanders KM, Pavlenko D, Lozada T, Akiyama T (2021) Crisaborole prevents infiltration of neutrophils to suppress itch in a mouse model of atopic dermatitis. Itch 6:e53\u2013e53. https:\/\/doi.org\/10.1097\/itx.0000000000000053","journal-title":"Itch"},{"key":"9004_CR135","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1165\/rcmb.2018-0065OC","volume":"60","author":"AE Dunne","year":"2019","unstructured":"Dunne AE et al (2019) Direct inhibitory effect of the PDE4 inhibitor roflumilast on neutrophil migration in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 60:445\u2013453. https:\/\/doi.org\/10.1165\/rcmb.2018-0065OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"9004_CR136","doi-asserted-by":"publisher","first-page":"139","DOI":"10.36849\/jdd.7295","volume":"22","author":"M Gooderham","year":"2023","unstructured":"Gooderham M et al (2023) The safety and efficacy of roflumilast cream 0.15% and 0.05% in patients with atopic dermatitis: randomized, double-blind, phase 2 proof of concept study. J Drugs Dermatol 22:139\u20131476. https:\/\/doi.org\/10.36849\/jdd.7295","journal-title":"J Drugs Dermatol"},{"key":"9004_CR137","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jid.2018.10.043","volume":"139","author":"EL Simpson","year":"2019","unstructured":"Simpson EL et al (2019) A phase 2 randomized trial of apremilast in patients with atopic dermatitis. J Invest Dermatol 139:1063\u20131072. https:\/\/doi.org\/10.1016\/j.jid.2018.10.043","journal-title":"J Invest Dermatol"},{"key":"9004_CR138","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13075-015-0771-6","volume":"17","author":"M Perez-Aso","year":"2015","unstructured":"Perez-Aso M et al (2015) Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors. Arthritis Res Ther 17:249. https:\/\/doi.org\/10.1186\/s13075-015-0771-6","journal-title":"Arthritis Res Ther"},{"key":"9004_CR139","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40265-020-01291-2","volume":"80","author":"S Dhillon","year":"2020","unstructured":"Dhillon S (2020) Delgocitinib: first approval. Drugs 80:609\u2013615. https:\/\/doi.org\/10.1007\/s40265-020-01291-2","journal-title":"Drugs"},{"key":"9004_CR140","doi-asserted-by":"publisher","first-page":"119558","DOI":"10.1016\/j.ijpharm.2020.119558","volume":"585","author":"H Kathuria","year":"2020","unstructured":"Kathuria H et al (2020) Proposome for transdermal delivery of tofacitinib. Int J Pharm 585:119558. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119558","journal-title":"Int J Pharm"},{"key":"9004_CR141","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/10600280221096713","volume":"57","author":"PO Perche","year":"2023","unstructured":"Perche PO, Cook MK, Feldman SR (2023) Abrocitinib: a new FDA-approved drug for moderate-to-severe atopic dermatitis. Ann Pharmacother 57:86\u201398. https:\/\/doi.org\/10.1177\/10600280221096713","journal-title":"Ann Pharmacother"},{"key":"9004_CR142","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/bjd.16004","volume":"179","author":"GJ Schmieder","year":"2018","unstructured":"Schmieder GJ et al (2018) Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study. Br J Dermatol 179:54\u201362. https:\/\/doi.org\/10.1111\/bjd.16004","journal-title":"Br J Dermatol"},{"key":"9004_CR143","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/all.16009","volume":"79","author":"S Muller","year":"2024","unstructured":"Muller S, Maintz L, Bieber T (2024) Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs. Allergy 79:1501\u20131515. https:\/\/doi.org\/10.1111\/all.16009","journal-title":"Allergy"},{"key":"9004_CR144","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40257-022-00684-1","volume":"23","author":"SM Hoy","year":"2022","unstructured":"Hoy SM (2022) Baricitinib: a review in moderate to severe atopic dermatitis. Am J Clin Dermatol 23:409\u2013420. https:\/\/doi.org\/10.1007\/s40257-022-00684-1","journal-title":"Am J Clin Dermatol"},{"key":"9004_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.03.1667","author":"M Okamoto","year":"2023","unstructured":"Okamoto M et al (2023) The inhibition of glycolysis in T cells by a Jak inhibitor ameliorates the pathogenesis of allergic contact dermatitis in mice. J Invest Dermatol. https:\/\/doi.org\/10.1016\/j.jid.2023.03.1667","journal-title":"J Invest Dermatol"},{"key":"9004_CR146","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1365-2133.2006.07609.x","volume":"156","author":"M Caproni","year":"2007","unstructured":"Caproni M et al (2007) The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study. Br J Dermatol 156:312\u2013319. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07609.x","journal-title":"Br J Dermatol"},{"key":"9004_CR147","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jmii.2014.07.006","volume":"49","author":"K-T Chang","year":"2016","unstructured":"Chang K-T, Lin HY-H, Kuo C-H, Hung C-H (2016) Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes. J Microbiol Immunol Infect 49:409\u2013416. https:\/\/doi.org\/10.1016\/j.jmii.2014.07.006","journal-title":"J Microbiol Immunol Infect"},{"key":"9004_CR148","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1517\/17425255.2013.819343","volume":"9","author":"H Prucha","year":"2013","unstructured":"Prucha H et al (2013) Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema. Expert Opin Drug Metab Toxicol 9:1507\u20131516. https:\/\/doi.org\/10.1517\/17425255.2013.819343","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"9004_CR149","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/bjd.21630","volume":"187","author":"T Bieber","year":"2022","unstructured":"Bieber T et al (2022) Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4). Br J Dermatol 187:338\u2013352. https:\/\/doi.org\/10.1111\/bjd.21630","journal-title":"Br J Dermatol"},{"key":"9004_CR150","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/all.14631","volume":"76","author":"D Siegels","year":"2021","unstructured":"Siegels D et al (2021) Systemic treatments in the management of atopic dermatitis: A systematic review and meta-analysis. Allergy 76:1053\u20131076. https:\/\/doi.org\/10.1111\/all.14631","journal-title":"Allergy"},{"key":"9004_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00054725-200201000-00001","volume":"8","author":"K Ina","year":"2002","unstructured":"Ina K et al (2002) Suppressive effects of cyclosporine A on neutrophils and T cells may be related to therapeutic benefits in patients with steroid-resistant ulcerative colitis. Inflamm Bowel Dis 8:1\u20139. https:\/\/doi.org\/10.1097\/00054725-200201000-00001","journal-title":"Inflamm Bowel Dis"},{"key":"9004_CR152","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2125.2009.03405.x","volume":"68","author":"SK Kham","year":"2009","unstructured":"Kham SK, Soh CK, Aw DC, Yeoh AE (2009) TPMT*26 (208F\u2013>L), a novel mutation detected in a Chinese. Br J Clin Pharmacol 68:120\u2013123. https:\/\/doi.org\/10.1111\/j.1365-2125.2009.03405.x","journal-title":"Br J Clin Pharmacol"},{"key":"9004_CR153","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jaad.2014.08.048","volume":"72","author":"NR Fuggle","year":"2015","unstructured":"Fuggle NR et al (2015) The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring. J Am Acad Dermatol 72:108\u2013114. https:\/\/doi.org\/10.1016\/j.jaad.2014.08.048","journal-title":"J Am Acad Dermatol"},{"key":"9004_CR154","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/bjd.18434","volume":"182","author":"A Wollenberg","year":"2020","unstructured":"Wollenberg A et al (2020) Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS). Br J Dermatol 182:1120\u20131135. https:\/\/doi.org\/10.1111\/bjd.18434","journal-title":"Br J Dermatol"},{"key":"9004_CR155","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2152\/jmi.63.187","volume":"63","author":"S Yoshida","year":"2016","unstructured":"Yoshida S, Yasutomo K, Watanabe T (2016) Treatment with DHA\/EPA ameliorates atopic dermatitis-like skin disease by blocking LTB4 production. J Med Invest 63:187\u2013191. https:\/\/doi.org\/10.2152\/jmi.63.187","journal-title":"J Med Invest"},{"key":"9004_CR156","doi-asserted-by":"publisher","first-page":"AB112","DOI":"10.1016\/j.jaad.2019.06.427","volume":"81","author":"A Fleischer","year":"2019","unstructured":"Fleischer A, Nam K, Kim J, Ahn K, Kang H, Choi J, Choi GJ, Lee S, Jung C (2019) Q301 (Zileuton) cream demonstrates superiority to vehicle in improving atopic dermatitis: Results from a phase 2A trial. JAAD 81:AB112. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.427","journal-title":"JAAD"},{"key":"9004_CR157","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s11096-018-0655-3","volume":"40","author":"WK Chin","year":"2018","unstructured":"Chin WK, Lee SWH (2018) A systematic review on the off-label use of montelukast in atopic dermatitis treatment. Int J Clin Pharm 40:963\u2013976. https:\/\/doi.org\/10.1007\/s11096-018-0655-3","journal-title":"Int J Clin Pharm"},{"key":"9004_CR158","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s13555-020-00389-5","volume":"10","author":"K Fahrbach","year":"2020","unstructured":"Fahrbach K et al (2020) Crisaborole ointment, 2%, for treatment of patients with mild-to-moderate atopic dermatitis: systematic literature review and network meta-analysis. Dermatol Ther (Heidelb) 10:681\u2013694. https:\/\/doi.org\/10.1007\/s13555-020-00389-5","journal-title":"Dermatol Ther (Heidelb)"},{"key":"9004_CR159","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","volume":"9","author":"H Li","year":"2018","unstructured":"Li H, Zuo J, Tang W (2018) Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases. Front Pharmacol 9:1048. https:\/\/doi.org\/10.3389\/fphar.2018.01048","journal-title":"Front Pharmacol"},{"key":"9004_CR160","doi-asserted-by":"publisher","first-page":"702677","DOI":"10.3389\/fphar.2021.702677","volume":"12","author":"L Totani","year":"2021","unstructured":"Totani L et al (2021) Type-4 phosphodiesterase (PDE4) blockade reduces NETosis in cystic fibrosis. Front Pharmacol 12:702677. https:\/\/doi.org\/10.3389\/fphar.2021.702677","journal-title":"Front Pharmacol"},{"key":"9004_CR161","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2147\/JEP.S259299","volume":"13","author":"KLE Hon","year":"2021","unstructured":"Hon KLE, Chan VPY, Leung AKC (2021) Experimental drugs with the potential to treat atopic eczema. J Exp Pharmacol 13:487\u2013498. https:\/\/doi.org\/10.2147\/JEP.S259299","journal-title":"J Exp Pharmacol"},{"key":"9004_CR162","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jaad.2017.06.010","volume":"77","author":"LF Eichenfield","year":"2017","unstructured":"Eichenfield LF et al (2017) Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis. J Am Acad Dermatol 77:641\u2013649. https:\/\/doi.org\/10.1016\/j.jaad.2017.06.010. (e645)","journal-title":"J Am Acad Dermatol"},{"key":"9004_CR163","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/pde.12872","volume":"33","author":"LT Zane","year":"2016","unstructured":"Zane LT et al (2016) Crisaborole topical ointment, 2% in patients ages 2 to 17 years with atopic dermatitis: a phase 1b, open-label, maximal-use systemic exposure study. Pediatr Dermatol 33:380\u2013387. https:\/\/doi.org\/10.1111\/pde.12872","journal-title":"Pediatr Dermatol"},{"key":"9004_CR164","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","volume":"75","author":"AS Paller","year":"2016","unstructured":"Paller AS et al (2016) Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol 75:494\u2013503. https:\/\/doi.org\/10.1016\/j.jaad.2016.05.046. (e496)","journal-title":"J Am Acad Dermatol"},{"key":"9004_CR165","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2340\/00015555-2893","volume":"98","author":"G Yosipovitch","year":"2018","unstructured":"Yosipovitch G et al (2018) Early relief of pruritus in atopic dermatitis with crisaborole ointment, a non-steroidal, phosphodiesterase 4 inhibitor. Acta Derm Venereol 98:484\u2013489. https:\/\/doi.org\/10.2340\/00015555-2893","journal-title":"Acta Derm Venereol"},{"key":"9004_CR166","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/exd.12377","volume":"23","author":"T Andoh","year":"2014","unstructured":"Andoh T, Yoshida T, Kuraishi Y (2014) Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis. Exp Dermatol 23:359\u2013361. https:\/\/doi.org\/10.1111\/exd.12377","journal-title":"Exp Dermatol"},{"key":"9004_CR167","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2217\/imt-2016-0023","volume":"8","author":"LT Zane","year":"2016","unstructured":"Zane LT et al (2016) Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies. Immunotherapy 8:853\u2013866. https:\/\/doi.org\/10.2217\/imt-2016-0023","journal-title":"Immunotherapy"},{"key":"9004_CR168","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0091-6749(92)90134-n","volume":"90","author":"D Tobin","year":"1992","unstructured":"Tobin D et al (1992) Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol 90:613\u2013622. https:\/\/doi.org\/10.1016\/0091-6749(92)90134-n","journal-title":"J Allergy Clin Immunol"},{"key":"9004_CR169","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201800354","author":"ZC Lin","year":"2018","unstructured":"Lin ZC et al (2018) Topical application of anthranilate derivatives ameliorates psoriatic inflammation in a mouse model by inhibiting keratinocyte-derived chemokine expression and neutrophil infiltration. FASEB J. https:\/\/doi.org\/10.1096\/fj.201800354","journal-title":"FASEB J"},{"key":"9004_CR170","doi-asserted-by":"publisher","DOI":"10.1002\/art.42486","author":"A Le Joncour","year":"2023","unstructured":"Le Joncour A et al (2023) Type-4 phosphodiesterase (PDE4) blockade reduces neutrophil activation in Behcet\u2019s disease. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.42486","journal-title":"Arthritis Rheumatol"},{"key":"9004_CR171","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/rheumatology\/key276","volume":"58","author":"GE Fragoulis","year":"2019","unstructured":"Fragoulis GE, McInnes IB, Siebert S, JAK-inhibitors (2019) New players in the field of immune-mediated diseases, beyond rheumatoid arthritis. Rheumatology (Oxford) 58:43\u201354. https:\/\/doi.org\/10.1093\/rheumatology\/key276","journal-title":"Rheumatology (Oxford)"},{"key":"9004_CR172","doi-asserted-by":"publisher","first-page":"e00537","DOI":"10.1002\/prp2.537","volume":"7","author":"ME Dowty","year":"2019","unstructured":"Dowty ME et al (2019) Janus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibition. Pharmacol Res Perspect 7:e00537. https:\/\/doi.org\/10.1002\/prp2.537","journal-title":"Pharmacol Res Perspect"},{"key":"9004_CR173","doi-asserted-by":"publisher","first-page":"968","DOI":"10.4049\/jimmunol.1102840","volume":"188","author":"R Goswami","year":"2012","unstructured":"Goswami R et al (2012) STAT6-dependent regulation of Th9 development. J Immunol 188:968\u2013975. https:\/\/doi.org\/10.4049\/jimmunol.1102840","journal-title":"J Immunol"},{"key":"9004_CR174","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","volume":"171","author":"LK Oetjen","year":"2017","unstructured":"Oetjen LK et al (2017) Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch. Cell 171:217\u2013228. https:\/\/doi.org\/10.1016\/j.cell.2017.08.006. (e213)","journal-title":"Cell"},{"key":"9004_CR175","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key075.474","author":"S Chokesuwattanaskul","year":"2018","unstructured":"Chokesuwattanaskul S et al (2018) 250 The effect of JAK inhibition on neutrophil killing, netosis and metabolism in rheumatoid arthritis. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/key075.474","journal-title":"Rheumatology"},{"key":"9004_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2023.01.020","author":"D Mikhaylov","year":"2023","unstructured":"Mikhaylov D, Ungar B, Renert-Yuval Y, Guttman-Yassky E (2023) Oral Janus kinase inhibitors for atopic dermatitis. Ann Allergy Asthma Immunol. https:\/\/doi.org\/10.1016\/j.anai.2023.01.020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"9004_CR177","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40257-020-00548-6","volume":"21","author":"S Ferreira","year":"2020","unstructured":"Ferreira S, Guttman-Yassky E, Torres T (2020) Selective JAK1 inhibitors for the treatment of atopic dermatitis: focus on upadacitinib and abrocitinib. Am J Clin Dermatol 21:783\u2013798. https:\/\/doi.org\/10.1007\/s40257-020-00548-6","journal-title":"Am J Clin Dermatol"},{"key":"9004_CR178","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.jaci.2019.11.025","volume":"145","author":"E Guttman-Yassky","year":"2020","unstructured":"Guttman-Yassky E et al (2020) Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial. J Allergy Clin Immunol 145:877\u2013884. https:\/\/doi.org\/10.1016\/j.jaci.2019.11.025","journal-title":"J Allergy Clin Immunol"},{"key":"9004_CR179","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad096","author":"A Torrelo","year":"2023","unstructured":"Torrelo A et al (2023) Efficacy and safety of baricitinib in combination with topical corticosteroids in pediatric patients with moderate-to-severe atopic dermatitis with inadequate response to topical corticosteroids: results from a phase 3, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS). Br J Dermatol. https:\/\/doi.org\/10.1093\/bjd\/ljad096","journal-title":"Br J Dermatol"},{"key":"9004_CR180","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40272-013-0013-9","volume":"15","author":"WW Carr","year":"2013","unstructured":"Carr WW (2013) Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations. Paediatr Drugs 15:303\u2013310. https:\/\/doi.org\/10.1007\/s40272-013-0013-9","journal-title":"Paediatr Drugs"},{"key":"9004_CR181","doi-asserted-by":"publisher","first-page":"CD009864","DOI":"10.1002\/14651858.CD009864.pub2","volume":"2015","author":"J Cury Martins","year":"2015","unstructured":"Cury Martins J et al (2015) Topical tacrolimus for atopic dermatitis. The Cochrane Database of Systematic Reviews 2015:CD009864. https:\/\/doi.org\/10.1002\/14651858.CD009864.pub2","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"9004_CR182","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jaci.2016.02.026","volume":"138","author":"S Imbert","year":"2016","unstructured":"Imbert S et al (2016) Calcineurin inhibitors impair neutrophil activity against Aspergillus fumigatus in allogeneic hematopoietic stem cell transplant recipients. J Allergy Clin Immunol 138:860\u2013868. https:\/\/doi.org\/10.1016\/j.jaci.2016.02.026","journal-title":"J Allergy Clin Immunol"},{"key":"9004_CR183","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/1346-8138.15730","volume":"48","author":"K Miyano","year":"2021","unstructured":"Miyano K, Tsunemi Y (2021) Current treatments for atopic dermatitis in Japan. J Dermatol 48:140\u2013151. https:\/\/doi.org\/10.1111\/1346-8138.15730","journal-title":"J Dermatol"},{"key":"9004_CR184","doi-asserted-by":"publisher","first-page":"e97088","DOI":"10.1371\/journal.pone.0097088","volume":"9","author":"AK Gupta","year":"2014","unstructured":"Gupta AK, Giaglis S, Hasler P, Hahn S (2014) Efficient neutrophil extracellular trap induction requires mobilization of both intracellular and extracellular calcium pools and is modulated by cyclosporine A. PLoS ONE 9:e97088. https:\/\/doi.org\/10.1371\/journal.pone.0097088","journal-title":"PLoS ONE"},{"key":"9004_CR185","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bcp.2019.03.022","volume":"163","author":"AM Liddicoat","year":"2019","unstructured":"Liddicoat AM, Lavelle EC (2019) Modulation of innate immunity by cyclosporine A. Biochem Pharmacol 163:472\u2013480. https:\/\/doi.org\/10.1016\/j.bcp.2019.03.022","journal-title":"Biochem Pharmacol"},{"key":"9004_CR186","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.jaad.2017.12.021","volume":"78","author":"DA Yanes","year":"2018","unstructured":"Yanes DA, Mosser-Goldfarb JL (2018) Emerging therapies for atopic dermatitis: The prostaglandin\/leukotriene pathway. J Am Acad Dermatol 78:S71\u2013S75. https:\/\/doi.org\/10.1016\/j.jaad.2017.12.021","journal-title":"J Am Acad Dermatol"},{"key":"9004_CR187","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1476-5381.2008.00012.x","volume":"156","author":"R Anderson","year":"2009","unstructured":"Anderson R et al (2009) Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism. Br J Pharmacol 156:105\u2013115. https:\/\/doi.org\/10.1111\/j.1476-5381.2008.00012.x","journal-title":"Br J Pharmacol"},{"key":"9004_CR188","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1080\/17476348.2019.1670640","volume":"13","author":"HKT Trinh","year":"2019","unstructured":"Trinh HKT, Lee SH, Cao TBT, Park HS (2019) Asthma pharmacotherapy: an update on leukotriene treatments. Expert Rev Respir Med 13:1169\u20131178. https:\/\/doi.org\/10.1080\/17476348.2019.1670640","journal-title":"Expert Rev Respir Med"},{"key":"9004_CR189","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4168\/aair.2016.8.4.305","volume":"8","author":"YH Jeon","year":"2016","unstructured":"Jeon YH, Min TK, Yang HJ, Pyun BY (2016) A double-blind, randomized, crossover study to compare the effectiveness of montelukast on atopic dermatitis in Korean children. Allergy Asthma Immunol Res 8:305\u2013311. https:\/\/doi.org\/10.4168\/aair.2016.8.4.305","journal-title":"Allergy Asthma Immunol Res"},{"key":"9004_CR190","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.plefa.2016.02.001","volume":"107","author":"J Zschaler","year":"2016","unstructured":"Zschaler J, Arnhold J (2016) Impact of simultaneous stimulation of 5-lipoxygenase and myeloperoxidase in human neutrophils. Prostaglandins Leukot Essent Fatty Acids 107:12\u201321. https:\/\/doi.org\/10.1016\/j.plefa.2016.02.001","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"9004_CR191","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1046\/j.0959-4493.2001.00254.x","volume":"12","author":"DW Crow","year":"2001","unstructured":"Crow DW, Marsella R, Nicklin CF (2001) Double-blinded, placebo-controlled, cross-over pilot study on the efficacy of zileuton for canine atopic dermatitis. Vet Dermatol 12:189\u2013195. https:\/\/doi.org\/10.1046\/j.0959-4493.2001.00254.x","journal-title":"Vet Dermatol"},{"key":"9004_CR192","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/10446670410001670445","volume":"11","author":"VA Ziboh","year":"2004","unstructured":"Ziboh VA et al (2004) Suppression of leukotriene B4 generation by ex-vivo neutrophils isolated from asthma patients on dietary supplementation with gammalinolenic acid-containing borage oil: possible implication in asthma. Clin Dev Immunol 11:13\u201321. https:\/\/doi.org\/10.1080\/10446670410001670445","journal-title":"Clin Dev Immunol"},{"key":"9004_CR193","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1194\/jlr.M800574-JLR200","volume":"50","author":"TL Hwang","year":"2009","unstructured":"Hwang TL et al (2009) Suppression of superoxide anion and elastase release by C18 unsaturated fatty acids in human neutrophils. J Lipid Res 50:1395\u20131408. https:\/\/doi.org\/10.1194\/jlr.M800574-JLR200","journal-title":"J Lipid Res"},{"key":"9004_CR194","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113222","author":"N Suzuki","year":"2020","unstructured":"Suzuki N et al (2020) Association between polyunsaturated fatty acid and reactive oxygen species production of neutrophils in the general population. Nutrients. https:\/\/doi.org\/10.3390\/nu12113222","journal-title":"Nutrients"},{"key":"9004_CR195","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.3389\/fimmu.2019.02507","volume":"10","author":"C Egholm","year":"2019","unstructured":"Egholm C, Heeb LEM, Impellizzieri D, Boyman O (2019) The regulatory effects of interleukin-4 receptor signaling on neutrophils in type 2 immune responses. Front Immunol 10:2507. https:\/\/doi.org\/10.3389\/fimmu.2019.02507","journal-title":"Front Immunol"},{"key":"9004_CR196","doi-asserted-by":"publisher","first-page":"7565","DOI":"10.7759\/cureus.7565","volume":"12","author":"A Tameez Ud Din","year":"2020","unstructured":"Tameez Ud Din A, Malik I, Arshad D, Tameez Ud Din A (2020) Dupilumab for atopic dermatitis: the silver bullet we have been searching for? Cureus 12:7565. https:\/\/doi.org\/10.7759\/cureus.7565","journal-title":"Cureus"},{"key":"9004_CR197","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jaad.2017.09.052","volume":"78","author":"P Fleming","year":"2018","unstructured":"Fleming P, Drucker AM (2018) Risk of infection in patients with atopic dermatitis treated with dupilumab: a meta-analysis of randomized controlled trials. J Am Acad Dermatol 78:62\u201369. https:\/\/doi.org\/10.1016\/j.jaad.2017.09.052. (e61)","journal-title":"J Am Acad Dermatol"},{"key":"9004_CR198","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/1744666X.2020.1858802","volume":"17","author":"C Tubau","year":"2021","unstructured":"Tubau C, Puig L (2021) Therapeutic targeting of the IL-13 pathway in skin inflammation. Expert Rev Clin Immunol 17:15\u201325. https:\/\/doi.org\/10.1080\/1744666X.2020.1858802","journal-title":"Expert Rev Clin Immunol"},{"key":"9004_CR199","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2500\/aap.2019.40.4202","volume":"40","author":"J Kim","year":"2019","unstructured":"Kim J, Kim BE, Leung DYM (2019) Pathophysiology of atopic dermatitis: Clinical implications. Allergy Asthma Proc 40:84\u201392. https:\/\/doi.org\/10.2500\/aap.2019.40.4202","journal-title":"Allergy Asthma Proc"},{"key":"9004_CR200","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jaad.2018.11.059","volume":"80","author":"EL Simpson","year":"2019","unstructured":"Simpson EL et al (2019) Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: a randomized phase 2a clinical trial. J Am Acad Dermatol 80:1013\u20131021. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.059","journal-title":"J Am Acad Dermatol"},{"key":"9004_CR201","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094369","author":"C Pelaia","year":"2021","unstructured":"Pelaia C et al (2021) Tezepelumab: a potential new biological therapy for severe refractory asthma. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22094369","journal-title":"Int J Mol Sci"},{"key":"9004_CR202","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/brb3.208","volume":"4","author":"R Bavarsad Shahripour","year":"2014","unstructured":"Bavarsad Shahripour R, Harrigan MR, Alexandrov AV (2014) N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Brain Behav 4:108\u2013122. https:\/\/doi.org\/10.1002\/brb3.208","journal-title":"Brain Behav"},{"key":"9004_CR203","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0192-0561(88)90148-8","volume":"10","author":"A Kharazmi","year":"1988","unstructured":"Kharazmi A, Nielsen H, Schiotz PO (1988) N-acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism. Int J Immunopharmacol 10:39\u201346. https:\/\/doi.org\/10.1016\/0192-0561(88)90148-8","journal-title":"Int J Immunopharmacol"},{"key":"9004_CR204","doi-asserted-by":"publisher","first-page":"450","DOI":"10.5021\/ad.2015.27.4.450","volume":"27","author":"K Nakai","year":"2015","unstructured":"Nakai K et al (2015) Effects of topical N-acetylcysteine on skin hydration\/transepidermal water loss in healthy volunteers and atopic dermatitis patients. Ann Dermatol 27:450\u2013451. https:\/\/doi.org\/10.5021\/ad.2015.27.4.450","journal-title":"Ann Dermatol"},{"key":"9004_CR205","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ajpath.2012.06.005","volume":"181","author":"K Nakai","year":"2012","unstructured":"Nakai K et al (2012) Reduced expression of epidermal growth factor receptor, E-cadherin, and occludin in the skin of flaky tail mice is due to filaggrin and loricrin deficiencies. Am J Pathol 181:969\u2013977. https:\/\/doi.org\/10.1016\/j.ajpath.2012.06.005","journal-title":"Am J Pathol"},{"key":"9004_CR206","doi-asserted-by":"publisher","first-page":"1032481","DOI":"10.3389\/fnut.2022.1032481","volume":"9","author":"DG Peroni","year":"2022","unstructured":"Peroni DG, Hufnagl K, Comberiati P, Roth-Walter F (2022) Lack of iron, zinc, and vitamins as a contributor to the etiology of atopic diseases. Front Nutr 9:1032481. https:\/\/doi.org\/10.3389\/fnut.2022.1032481","journal-title":"Front Nutr"},{"key":"9004_CR207","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/jdv.15524","volume":"33","author":"NA Gray","year":"2019","unstructured":"Gray NA, Dhana A, Stein DJ, Khumalo NP (2019) Zinc and atopic dermatitis: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 33:1042\u20131050. https:\/\/doi.org\/10.1111\/jdv.15524","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9004_CR208","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/imcb.12509","volume":"100","author":"W Kuzmicka","year":"2022","unstructured":"Kuzmicka W et al (2022) Iron excess affects release of neutrophil extracellular traps and reactive oxygen species but does not influence other functions of neutrophils. Immunol Cell Biol 100:87\u2013100. https:\/\/doi.org\/10.1111\/imcb.12509","journal-title":"Immunol Cell Biol"},{"key":"9004_CR209","doi-asserted-by":"publisher","DOI":"10.3390\/nu13010051","author":"W Kuzmicka","year":"2020","unstructured":"Kuzmicka W et al (2020) Zinc supplementation modulates NETs release and neutrophils\u2019 degranulation. Nutrients. https:\/\/doi.org\/10.3390\/nu13010051","journal-title":"Nutrients"},{"key":"9004_CR210","first-page":"91","volume":"122","author":"S Holt","year":"2009","unstructured":"Holt S et al (2009) A pilot study of the efficacy of a vitamin C-containing showerhead on symptoms of eczema. N Z Med J 122:91\u201392","journal-title":"N Z Med J"},{"key":"9004_CR211","doi-asserted-by":"publisher","first-page":"e27666","DOI":"10.7759\/cureus.27666","volume":"14","author":"JV Camilion","year":"2022","unstructured":"Camilion JV, Khanna S, Anasseri S, Laney C, Mayrovitz HN (2022) Physiological, pathological, and circadian factors impacting skin hydration. Cureus 14:e27666. https:\/\/doi.org\/10.7759\/cureus.27666","journal-title":"Cureus"},{"key":"9004_CR212","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/jdv.12176","volume":"28","author":"TR Hata","year":"2014","unstructured":"Hata TR et al (2014) A randomized controlled double-blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis. J Eur Acad Dermatol Venereol 28:781\u2013789. https:\/\/doi.org\/10.1111\/jdv.12176","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9004_CR213","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/03009739109179263","volume":"96","author":"R Luostarinen","year":"1991","unstructured":"Luostarinen R, Siegbahn A, Saldeen T (1991) Effects of dietary supplementation with vitamin E on human neutrophil chemotaxis and generation of LTB4. Ups J Med Sci 96:103\u2013111. https:\/\/doi.org\/10.3109\/03009739109179263","journal-title":"Ups J Med Sci"},{"key":"9004_CR214","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1159\/000510653","volume":"237","author":"CWL Teo","year":"2021","unstructured":"Teo CWL, Tay SHY, Tey HL, Ung YW, Yap WN (2021) Vitamin E in atopic dermatitis: from preclinical to clinical studies. Dermatology 237:553\u2013564. https:\/\/doi.org\/10.1159\/000510653","journal-title":"Dermatology"},{"key":"9004_CR215","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1111\/1346-8138.16126","volume":"48","author":"L Zhang","year":"2021","unstructured":"Zhang L, Du D, Wang L, Guo L, Jiang X (2021) Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: a network meta-analysis. J Dermatol 48:1877\u20131883. https:\/\/doi.org\/10.1111\/1346-8138.16126","journal-title":"J Dermatol"},{"key":"9004_CR216","doi-asserted-by":"publisher","first-page":"1079323","DOI":"10.3389\/fmed.2022.1079323","volume":"9","author":"Y Rodriguez-Le Roy","year":"2022","unstructured":"Rodriguez-Le Roy Y, Ficheux AS, Misery L, Brenaut E (2022) Efficacy of topical and systemic treatments for atopic dermatitis on pruritus: a systematic literature review and meta-analysis. Front Med (Lausanne) 9:1079323. https:\/\/doi.org\/10.3389\/fmed.2022.1079323","journal-title":"Front Med (Lausanne)"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-024-09004-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-024-09004-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-024-09004-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T13:23:53Z","timestamp":1734009833000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-024-09004-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":216,"journal-issue":{"issue":"1-3","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9004"],"URL":"https:\/\/doi.org\/10.1007\/s12016-024-09004-3","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"27 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}